homovanillic acid has been researched along with Bulimia in 8 studies
Homovanillic Acid: A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid.
homovanillate : A hydroxy monocarboxylic acid anion which is obtained by deprotonation of the carboxy group of homovanillic acid.
homovanillic acid : A monocarboxylic acid that is the 3-O-methyl ether of (3,4-dihydroxyphenyl)acetic acid. It is a catecholamine metabolite.
Bulimia: Eating an excess amount of food in a short period of time, as seen in the disorder of BULIMIA NERVOSA. It is caused by an abnormal craving for food, or insatiable hunger also known as ox hunger.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Brofaromine or placebo were administered to female bulimia nervosa patients over a period of eight weeks." | 9.07 | The effect of the MAO-A selective inhibitor brofaromine on the plasma and urine concentrations of some biogenic amines and their acidic metabolites in bulimia nervosa. ( Boulton, AA; D'Souza, J; Davis, BA; Durden, DA; Goldbloom, DS; Kennedy, SH, 1993) |
| " Brofaromine or placebo were administered to female bulimia nervosa patients over a period of eight weeks." | 5.07 | The effect of the MAO-A selective inhibitor brofaromine on the plasma and urine concentrations of some biogenic amines and their acidic metabolites in bulimia nervosa. ( Boulton, AA; D'Souza, J; Davis, BA; Durden, DA; Goldbloom, DS; Kennedy, SH, 1993) |
| " In this study, we examined cerebrospinal fluid levels of the major monoamine metabolites and beta-endorphin in patients with eating disorders (11 with anorexia nervosa, 16 with bulimia nervosa), while they were acutely ill." | 3.68 | Relation of dissociative phenomena to levels of cerebrospinal fluid monoamine metabolites and beta-endorphin in patients with eating disorders: a pilot study. ( Altemus, M; Demitrack, MA; Gold, PW; Krahn, DD; Pigott, TA; Putnam, FW; Rubinow, DR, 1993) |
| " In comparison with healthy controls (N = 17), hospitalized bulimic patients with a history of binge eating more frequently than twice daily (N = 11) had significantly lower CSF concentrations of 5-hydroxyindoleacetic acid and homovanillic acid." | 3.68 | Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes. ( Brewerton, TD; Jimerson, DC; Kaye, WH; Lesem, MD, 1992) |
| "The hyperphagia was further enhanced when they were put in a space-restricted cage where their mobility was restricted." | 1.30 | Prefrontal and striatal dopamine metabolism during enhanced rebound hyperphagia induced by space restriction--a rat model of binge eating. ( Fujisaki, Y; Inoue, K; Iwasaki, S; Kiriike, N; Kurioka, M; Okuno, M; Yamagami, S, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, BA | 2 |
| Kennedy, SH | 2 |
| Durden, DA | 1 |
| D'Souza, J | 2 |
| Goldbloom, DS | 1 |
| Boulton, AA | 1 |
| Brown, GM | 1 |
| Ford, CG | 1 |
| Demitrack, MA | 1 |
| Putnam, FW | 1 |
| Rubinow, DR | 1 |
| Pigott, TA | 1 |
| Altemus, M | 1 |
| Krahn, DD | 1 |
| Gold, PW | 1 |
| Halmi, KA | 1 |
| Kaye, WH | 3 |
| Greeno, CG | 1 |
| Moss, H | 1 |
| Fernstrom, J | 1 |
| Fernstrom, M | 1 |
| Lilenfeld, LR | 1 |
| Weltzin, TE | 1 |
| Mann, JJ | 1 |
| Inoue, K | 1 |
| Kiriike, N | 1 |
| Okuno, M | 1 |
| Fujisaki, Y | 1 |
| Kurioka, M | 1 |
| Iwasaki, S | 1 |
| Yamagami, S | 1 |
| Jimerson, DC | 1 |
| Lesem, MD | 1 |
| Brewerton, TD | 1 |
| Ballenger, JC | 1 |
| Lydiard, RB | 1 |
| Stuart, GW | 1 |
| Laraia, MT | 1 |
| O'Neil, P | 1 |
| Fossey, MD | 1 |
| Stevens, V | 1 |
| Lesser, S | 1 |
| Hsu, G | 1 |
1 review available for homovanillic acid and Bulimia
| Article | Year |
|---|---|
Eating disorder research in the past decade.
Topics: Anorexia Nervosa; Body Image; Bulimia; Cognitive Behavioral Therapy; Family; Homovanillic Acid; Huma | 1996 |
2 trials available for homovanillic acid and Bulimia
| Article | Year |
|---|---|
The effect of the MAO-A selective inhibitor brofaromine on the plasma and urine concentrations of some biogenic amines and their acidic metabolites in bulimia nervosa.
Topics: Biogenic Amines; Bulimia; Double-Blind Method; Female; Homovanillic Acid; Humans; Hydroxyindoleaceti | 1993 |
Effects of chronic brofaromine administration on biogenic amines including sulphatoxymelatonin and acid metabolites in patients with bulimia nervosa.
Topics: Adolescent; Adult; Biogenic Amines; Bulimia; Female; Homovanillic Acid; Humans; Hydrogen-Ion Concent | 1993 |
5 other studies available for homovanillic acid and Bulimia
| Article | Year |
|---|---|
Relation of dissociative phenomena to levels of cerebrospinal fluid monoamine metabolites and beta-endorphin in patients with eating disorders: a pilot study.
Topics: Adolescent; Adult; Anorexia Nervosa; beta-Endorphin; Body Weight; Brain; Bulimia; Dissociative Disor | 1993 |
Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa.
Topics: Adolescent; Adult; Affect; Body Weight; Brain Chemistry; Bulimia; Feeding Behavior; Female; Follow-U | 1998 |
Prefrontal and striatal dopamine metabolism during enhanced rebound hyperphagia induced by space restriction--a rat model of binge eating.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bulimia; Chromatography, High Pressure Liquid; Disease Mode | 1998 |
Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes.
Topics: Adult; Body Weight; Bulimia; Dopamine; Eating; Female; Homovanillic Acid; Humans; Hydroxyindoleaceti | 1992 |
CSF monoamine levels in normal-weight bulimia: evidence for abnormal noradrenergic activity.
Topics: Adult; Biogenic Monoamines; Bulimia; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Ne | 1990 |